SNG Hawk’s Nest is Back for Year Two!

MaRS Discovery District
November 22, 2018
6 pm – 10 pm

Supporting Canadian
Medical Innovation



Toronto’s medtech scene is BOOMING! Across the city’s incubators, we screen and interview dozens of pitch applications from the city’s most promising emerging medtech companies.



Our 4 most promising applicants are invited to pitch their companies live on November 22 in front of our all-star panel of “Hawks” and a 300+ person audience.



The winning company will leave the event with a NON-DILUTIVE CHEQUE for 50% of the event’s net proceeds (up to a maximum of $50,000), with all remaining proceeds being donated to the Sunnybrook Medventions Program!

Meet Our 2018 Finalists…

Cyclica is Toronto-based and venture-backed biotechnology company that is revolutionizing next generation drug discovery by empowering pharmaceutical scientists with a cloud-based and AI-augmented platform to enhance how scientists design, screen, and personalize medicines, all for the purpose of designing better therapeutics that enhance patient outcomes.

Conventional 2D X-rays cannot screen for lung cancer because lung tissue is obscured by overlying bones leading to CAT scans that are radiation intensive, have slower workflows and higher lifetime ownership costs than 2D X-ray. Just like your eye sees 3 colors, Waterloo start-up KA Imaging has created a revolutionary 2D X-ray detector retrofit solution that can “see” different X-ray energy levels, which enables clear lung tissue visualization by subtracting bone and other unwanted materials.

MIMOSA Diagnostics is a leading mHealth innovator that is building the next generation of patient monitoring and assessment tools. Driven by AI and delivered through the cloud, MIMOSA uses multi-spectral mobile tissue analysis to go beyond anatomy to assess and measure the physiology of tissue health and viability. MIMOSA enhances remote monitoring and assessment via real-time insights, enabling better treatment decisions and outcomes for each patient.

Steadiwear is a Toronto-based medical device company that has developed the Steadi-One, a lightweight, compact and battery-free glove that uses cutting-edge damping technology to stabilize the wrist and improve tactile functionality in Parkinson’s Disease and Essential Tremor patients. 

Meet The Hawk’s Nest Panel…



Co-Founder & CEO, Bloom Burton & Co.

Founded in 2008, Bloom Burton & Co. is Canada’s pre-eminent healthcare sector financial advisory firm, offering a wide variety of services that work together to identify, cultivate and create investment opportunities on behalf of companies and investors alike. The firm offers M&A advisory, capital raising and financing, equity research, monetization planning, direct investment, and transaction support services to the healthcare industry.



Co-Founder & CIO, EdgeStone Capital Partners

EdgeStone Capital Partners is one of Canada’s largest and most successful private equity funds. Since its inception in 1999, EdgeStone has managed in excess of $2 billion for institutional and high-net-worth investors, across a range of private capital vehicles including private equity, venture capital, mezzanine debt, and energy funds, as well as a fund-of-funds.



Founder, M5.0 Inc.

Andrea has always been driven by three core principles in her career: work smarter, not harder; innovate constantly; be curious about what’s next. She is a forward-thinking leader and an elite problem solver. Andrea helps companies look at problems differently, and answer complex business questions from strategy through execution faster. She has built three startups from zero to successful exit. The largest was from zero to US$175 million in 24 months on three continents.



Partner, Lumira Capital

With over 20 years of life science, IT and business development executive-level experience, Jacki is a key member of Lumira Capital’s senior management team, where her responsibilities include financial analysis, industry intelligence, proactive deal sourcing and structuring, and fundraising. Jacki also directs all aspects of Lumira’s IT initiatives, a role in which she has developed a world class venture capital analytics platform.



Co-Founder & CEO, Intellijoint Surgical Inc.

Based in Waterloo, ON, Intellijoint Surgical has successfully developed and launched a state of the art surgical camera (and supporting software) that is used by orthopedic surgeons to greatly improve clinical outcomes in hip replacement surgeries without materially increasing surgical procedure lengths. Intellijoint has raised over $18M in funding to date and is widely regarded as one of Canada’s most promising medical technology companies.

Our Cause: Sunnybrook Medventions Program

Despite possessing many ingredients for success, including a well-educated population and a high-quality health care system with strong clinical research capabilities, Canada imports $8.6 billion in medical devices every year while exporting just $3 million of the same. While many Canadians have the ability to make medical discoveries, few know how to take a medical device from idea to prototype through commercialization.

To take the lead in addressing this domestic skills gap, Sunnybrook launched its flagship Medventions program, which provides scientists, clinicians and engineers alike with a streamlined entrepreneurial training approach focused on nurturing local medtech expertise.

Medventions’ dual mandate is to both pave the way for new generations of medtech-gadgets that directly target unmet clinical needs and mentor its participants in the complexities of bringing their innovations from bench to bedside. Key components of the program include innovation internships, a bi-weekly medtech innovation seminar, an annual innovation symposium, and an online medtech community portal.

Medventions’ ultimate goal is to enable both patients and the Canadian health care system as a whole to reap the benefits of the medical inventions that emerge from its program, and it is with programs such as Medventions that Sunnybrook will ultimately realize its goal of inventing the future of healthcare.

Highlights from 2017

  • 40+ applicants screened
  • 20 corporate sponsorships/partnerships received
  • 300 attendees, including the Ontario Minister of Research, Innovation, and Science
  • Press coverage in the National Post, University of Toronto Press, Toronto Sun, & BetaKit
  • $38,000 raised in support of the Sunnybrook Research Institute
  • $38,000 raised in support of the winner of Hawk’s Nest 2017, Trexo Robotics
  • Unanimously positive feedback received from attendees, contestants, judges, and volunteers alike

The 2017 Finalists

People’s own cells and genomes will become the foundation of future biomedical therapeutics. Aged cells, however, are highly mutated, deteriorated versions of our current cells. Acorn Biolabs has developed a mail-in non-invasive cell collection kit to cryopreserve and sequence people’s cells, empowering them with information today and preparing them for future therapeutics.

At RetiSpec, we are developing a non-invasive retinal scanner that detects Alzheimer’s pathology years before the onset of symptoms. Our technology aims to help pharmaceutical companies optimize expensive patient screening processes for Alzheimer’s-related clinical trials and more importantly, help clinicians diagnose and treat Alzheimer’s at earlier stages of onset, when patients are typically much more responsive to intervening therapeutics and other forms of treatment.

VivaVax creates biosafe formulations that protect sensitive medications from breaking down during transport & storage. We offer better temperature resistance with a 2-3X spoilage improvement over current technologies.

The 2017 Champion: Trexo Robotics

  • Founded in 2016 by University of Waterloo engineering graduates Manmeet Maggu and Rahul Udasi, Tréxō Robotics has designed the first human exoskeleton device catering specifically towards children with movement disabilities. Tréxō’s unique device can convert any passive walker into a fully-powered human exoskeleton that can be used anywhere, anytime, and at a fraction of the price of currently available competitor devices.
  • Since winning Hawk’s Nest last year, Tréxō launched its first clinical trial at the Cincinnati Children’s Hospital Medical Centre – the largest pediatric rehabilitation centre in North America – and recently received an LOI for a second trial at the St. Mary’s Hospital for Children in New York City. The company also recently rolled out a second generation device to improve on its previous exoskeleton’s design.
  • Tréxō is driven by the passionate belief that nobody should be constrained to life in a wheelchair, and is on a mission to redefine mobility solutions for all!


Tréxō Robotics is building the first exoskeleton device designed specifically for children with disabilities. Tréxō’s unique design allows it to convert any passive walker into a fully powered exoskeleton device that can be used anywhere, at any time, at a fraction of the price of currently available competitor devices. Founded in 2016 by two University of Waterloo engineering graduates, Tréxō is driven by the belief that people shouldn’t be constrained to a wheelchair, and is on a mission to redefine mobility solutions for all.

Who We Are

Hawk’s Nest is brought to you by Sunnybrook Next Generation (SNG). SNG is a group of young professional volunteer advocates and ambassadors that supports the mission and goals of Sunnybrook by engaging a new generation of supporters through awareness initiatives, fundraising activities, and active participation in the community of Sunnybrook.

SNG has built and continues to build a strong core group of volunteer leaders who are passionate about Sunnybrook and healthcare in general. Through its social calendar, SNG provides professional and social networking opportunities to its membership and the young professional community at large while raising funds for the hospital’s highest priority needs.

Message From The Chairs

Dear Friend of Sunnybrook,

On behalf of SNG, welcome! Your interest in our mission and goals is what fuels us to support Sunnybrook’s highest priority needs.

Since 2014, SNG has consistently demonstrated itself as an organization capable of achieving tremendous success across a wide range of fundraising, community engagement and educational outreach initiatives. With the collective efforts of our executive, committees and general members, we strive to educate the next generation of Sunnybrook’s community leaders, while raising critical funds to help Sunnybrook remain at the forefront of medical innovation – both now and for decades to come.

The success of Hawk’s Nest 2017 helped accelerate the growth of SNG in a big way and generated tremendous publicity for both Sunnybrook as a whole and the four incredible finalists who pitched at our event.

While we were thrilled by the success of our inaugural event, we believe that we still have ample room and opportunity to grow our franchise. Our vision is to make Hawk’s Nest THE premier startup pitch competition in Canada, and to achieve that goal we will need many more sponsors, media partners, volunteers, and high profile attendees alike.

Your support of Hawk’s Nest means the world to us and with your help, we look forward to taking Hawk’s Nest to even greater heights this year. We hope you will consider supporting our event and please join us on November 22nd for a night of fun and inspiration!


Jesse Buckstein & David Tile

Co-Chairs, SNG Hawk’s Nest

Jesse Buckstein

Jesse Buckstein

Principal, CPOINT Capital

David Tile

David Tile

Founder, Nimble Media


Give us a shout anytime!

14 + 7 =